Metastatic components in colorectal cancer

被引:7
|
作者
Javarsiani, Marjan Hajimoradi [1 ]
Javanmard, Shagayegh Haghjooy [2 ]
Colonna, Francesca [3 ]
机构
[1] Shiraz Univ, Sch Vet Med, Dept Basic Sci, Shiraz, Iran
[2] Isfahan Univ Med Sci, Appl Physiol Res Ctr, Cardiovasc Res Inst, Esfahan, Iran
[3] Cattolica Sacro Cuore Largo Francesco Univ, Dept Gen Pathol, Rome, Italy
关键词
Cancer stem cells; colorectal cancer; metastasis; tumor microenvironment; GROWTH-FACTOR RECEPTOR; STROMAL FIBROBLASTS; TUMOR ANGIOGENESIS; STEM-CELLS; EXPRESSION; HETEROGENEITY; ACTIVATION; MODEL; SMAD4;
D O I
10.4103/jrms.JRMS_957_18
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Recent experiments have shown that cells with different genetic mutations can give rise to cancer transformation, both in vitro and in vivo, supported by the crosstalk between cancer cells and stroma. The stroma and the complex set of involved cells make up the tumor microenvironment that supports the engraftment of metastatic cells. In fact, environmental factors support colorectal cancer arise by formation and maintenance of cancer stem cells (CSCs). In this review, we discuss interactions between CSCs and their microenvironment that can provide better therapeutic opportunities in the metastatic cancer.
引用
收藏
页数:7
相关论文
共 50 条
  • [41] Metastatic colorectal cancer to a primary thyroid cancer
    Cherk, Martin H.
    Moore, Maggie
    Serpell, Jonathan
    Swain, Sarah
    Topliss, Duncan J.
    WORLD JOURNAL OF SURGICAL ONCOLOGY, 2008, 6 (1)
  • [42] Metastatic colorectal cancer to a primary thyroid cancer
    Martin H Cherk
    Maggie Moore
    Jonathan Serpell
    Sarah Swain
    Duncan J Topliss
    World Journal of Surgical Oncology, 6
  • [43] COLORECTAL CANCER Metastatic colorectal cancer outcome and fatty liver disease
    Brouquet, Antoine
    Nordlinger, Bernard
    NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY, 2013, 10 (05) : 266 - 267
  • [44] Updates in the Treatment of Metastatic Colorectal Cancer
    Malla, Midhun
    Pedersen, Katrina S.
    Parikh, Aparna R.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2023, 21 (5.5): : 567 - 571
  • [45] Economics of ramucirumab for metastatic colorectal cancer
    Zeichner, Simon B.
    Kohn, Christine G.
    Goldstein, Daniel A.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2016, 16 (06) : 733 - 745
  • [46] Systemic therapy of metastatic colorectal cancer
    Kubicka, S.
    ONKOLOGE, 2014, 20 (08): : 725 - +
  • [47] The clonal evolution of metastatic colorectal cancer
    Dang, Ha X.
    Krasnick, Bradley A.
    White, Brian S.
    Grossman, Julie G.
    Strand, Matthew S.
    Zhang, Jin
    Cabanski, Christopher R.
    Miller, Christopher A.
    Fulton, Robert S.
    Goedegebuure, S. Peter
    Fronick, Catrina C.
    Griffith, Malachi
    Larson, David E.
    Goetz, Brian D.
    Walker, Jason R.
    Hawkins, William G.
    Strasberg, Steven M.
    Linehan, David C.
    Lim, Kian H.
    Lockhart, A. Craig
    Mardis, Elaine R.
    Wilson, Richard K.
    Ley, Timothy J.
    Maher, Christopher A.
    Fields, Ryan C.
    SCIENCE ADVANCES, 2020, 6 (24)
  • [48] Optimum chemotherapy for metastatic colorectal cancer
    Bendell, Johanna
    LANCET, 2006, 368 (9552): : 2039 - 2041
  • [49] COMORBIDITIES IN PATIENTS WITH METASTATIC COLORECTAL CANCER
    Fu, A. Z.
    Zhao, Z.
    Wang, P. F.
    Barber, B.
    Liu, G.
    VALUE IN HEALTH, 2009, 12 (07) : A257 - A257
  • [50] Carcinoembryonic antigen in metastatic colorectal cancer
    Hamm, CM
    Cripps, C
    CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 1998, 21 (4-5): : 186 - 191